index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chiffres clés

54 Publications avec texte intégral

Open Access

46 %

Mots clés

Heart failure Innate immunity DICER Antimir-150 Germinal centers Immunotherapy Cellules th17 Auto-immunité Immunity Macrophages Long-term follow-up Exercise CXCL13-CXCR5 COVID-19 Acetylcholine receptor Autoimmune diseases Disease susceptibility Complete Freund's adjuvant Germinal center Interferon type I Early-onset myasthenia gravis BAFF Glucocorticoids Thymoma Immune response Interleukine-23 Quality of life Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Human myoblasts Myasthenia gravis Chemokine Interferon IFN Autoimmune disease Chronicity Genetics M3243AG Interferon type-I CD31 Interleukin 23 Endogenous nucleic acids Autoimmunity Etiology Age CCL21 Maladie auto-immune MYB Transcriptome Acetylcholine receptors PBMC Animal models Ectopic germinal centers Thymic epithelial cells MG patients Interferon de type I Genetic associations Myasthenia Gravis MG Acides nucléiques endogènes Thymus Immunology and Microbiology Section AChR antibodies Clinical cell transplantation Interferon Experimental autoimmune myasthenia gravis Centres germinatifs ectopiques Chronic inflammation Myoblasts Chemokines Experimental autoimmune myasthenia gravis EAMG Experimental models Il-23 CTCF Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Inflammation Fragile X syndromes Th17 cells Myasthénie grave Neuromuscular junction Follicular hyperplasia Cytokines Interferon-β Anticorps monoclonal Interferonopathy Ferrites Cardiomyopathy Inflammatory cytokines Interféron de type I B cells Lamin A/C nuclei LMNA FMR1 Gender Experimental mouse models Immune regulation Mass cytometry CyTOF Max Gd T cells Acetylcholine receptor antibodies Adaptive immunity Conduction disease COX2